TRACON Pharmaceuticals (TCON) Stock Chart & Stock Price History → BUY ALERT: Tiny tech play partners with US government (From Stansberry Research) (Ad) Free TCON Stock Alerts $1.41 -0.10 (-6.62%) (As of 11:15 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends TRACON Pharmaceuticals Stock Price Performance5 Day Performance-5.36%1 Month Performance-18.49%3 Month Performance-61.05%6 Month Performance-65.52%Year-To-Date Performance-59.73%1 Year Performance-87.77% Receive TCON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchBUY ALERT: Tiny tech play partners with US governmentThe Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).Get the full story here while you can. TCON Stock Chart for Thursday, May, 30, 2024 TCON Chart by TradingView TRACON Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/29/2024$1.50$1.51+0.67%$1.52$1.4878,341 shs$4.05 million05/28/2024$1.49$1.50+0.67%$1.53$1.4835,473 shs$4.02 million05/27/2024$1.49$1.49$1.54$1.4856,400 shs$3.99 million05/24/2024$1.52$1.49-1.97%$1.54$1.4956,445 shs$3.99 million05/23/2024$1.50$1.52+1.33%$1.55$1.49122,904 shs$4.07 million05/22/2024$1.49$1.50+0.67%$1.54$1.4751,372 shs$4.02 million Get the Latest News and Ratings for TCON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/21/2024$1.44$1.49+3.47%$1.49$1.4248,859 shs$3.99 million05/20/2024$1.43$1.44+0.70%$1.52$1.4183,613 shs$3.86 million05/17/2024$1.53$1.43-6.54%$1.58$1.42119,416 shs$3.83 million05/16/2024$1.62$1.53-5.56%$1.68$1.52100,623 shs$3.49 million05/15/2024$1.97$1.62-17.77%$1.70$1.52201,953 shs$3.69 million05/14/2024$2.02$1.97-2.48%$2.06$1.95142,389 shs$4.49 million05/13/2024$1.93$2.02+4.66%$2.05$1.91149,649 shs$4.61 million05/10/2024$1.83$1.93+5.46%$2.05$1.80449,036 shs$4.39 million05/09/2024$1.76$1.83+3.98%$1.83$1.72131,163 shs$4.16 million05/08/2024$1.82$1.76-3.30%$1.84$1.71114,158 shs$4.01 million05/07/2024$1.81$1.82+0.55%$1.84$1.7490,867 shs$4.15 million05/06/2024$1.86$1.81-2.69%$1.92$1.77106,509 shs$4.13 million05/03/2024$1.81$1.86+2.76%$1.94$1.80260,844 shs$4.24 million05/02/2024$1.71$1.81+5.85%$1.87$1.72144,773 shs$4.13 million05/01/2024$1.73$1.71-1.16%$1.85$1.69187,825 shs$3.90 million04/30/2024$1.88$1.73-7.98%$1.95$1.70191,012 shs$3.94 million04/29/2024$1.81$1.88+3.87%$2.10$1.81243,119 shs$4.29 million04/26/2024$1.79$1.81+1.12%$1.88$1.70206,618 shs$4.13 million04/25/2024$1.89$1.79-5.29%$1.97$1.76128,568 shs$4.08 million04/24/2024$1.85$1.89+2.16%$1.94$1.8364,665 shs$4.30 million04/23/2024$1.82$1.85+1.65%$1.96$1.8254,919 shs$4.22 million04/22/2024$1.96$1.82-7.14%$1.94$1.70143,340 shs$4.15 million04/19/2024$2.11$1.96-7.11%$2.14$1.93239,102 shs$4.47 million04/18/2024$2.29$2.11-7.86%$2.34$2.06351,085 shs$4.81 million04/17/2024$1.71$2.29+33.92%$2.89$1.711.97 million shs$5.22 million04/16/2024$1.80$1.71-5.00%$1.93$1.59263,900 shs$3.90 million04/15/2024$2.36$1.80-23.73%$2.28$1.72253,730 shs$4.10 million04/12/2024$2.59$2.36-8.88%$2.65$2.25307,162 shs$5.38 million04/11/2024$3.01$2.59-13.95%$3.37$2.55214,005 shs$117.86 million04/10/2024$3.36$3.01-10.47%$3.14$2.70285,094 shs$136.97 million04/09/2024$3.84$3.36-12.45%$4.08$3.03203,320 shs$7.65 million04/08/2024$5.11$3.84-24.79%$5.00$3.70343,615 shs$8.74 million04/05/2024$5.25$5.11-2.67%$5.40$4.6094,143 shs$11.62 million04/04/2024$4.39$5.25+19.50%$5.58$4.52430,170 shs$11.94 millionBUY ALERT: Tiny tech play partners with US government (Ad)The Federal Reserve is rolling out a powerful new financial technology across the entire U.S. banking system. It's forecasted to grow 24,290% in the near future... Meaning, your bank is nearly certain to adopt it (if it hasn't already).Get the full story here while you can.04/03/2024$8.31$4.39-47.18%$8.08$3.72841,811 shs$9.99 million04/02/2024$8.23$8.31+1.05%$8.54$8.0057,583 shs$18.91 million04/01/2024$8.60$8.23-4.30%$8.83$8.2069,365 shs$18.72 million03/29/2024$8.60$8.60$9.20$7.94156,697 shs$19.56 million03/28/2024$8.20$8.60+4.80%$9.20$7.94155,517 shs$19.56 million03/27/2024$8.60$8.20-4.63%$8.60$7.8079,852 shs$18.66 million03/26/2024$9.20$8.60-6.52%$9.20$7.80167,323 shs$19.57 million03/25/2024$9.13$9.20+0.74%$10.00$8.81184,200 shs$20.93 million03/22/2024$8.74$9.13+4.49%$11.00$8.90506,909 shs$20.78 million03/21/2024$7.44$8.74+17.47%$9.00$7.21310,354 shs$19.89 million03/20/2024$7.79$7.44-4.49%$8.00$7.02114,730 shs$16.93 million03/19/2024$7.22$7.79+7.86%$10.20$6.74448,179 shs$17.73 million03/18/2024$7.50$7.22-3.71%$7.60$5.78418,046 shs$16.43 million03/15/2024$8.75$7.50-14.31%$8.60$7.02326,652 shs$11.68 million03/14/2024$12.62$8.75-30.65%$12.40$7.131.03 million shs$13.63 million03/13/2024$7.80$12.62+61.79%$14.75$7.801.32 million shs$19.65 million03/12/2024$5.80$7.80+34.48%$8.02$6.30925,830 shs$12.15 million03/11/2024$4.94$5.80+17.41%$5.88$4.62372,426 shs$9.03 million03/08/2024$4.65$4.94+6.24%$5.20$4.50268,862 shs$7.69 million03/07/2024$3.94$4.65+18.02%$4.80$3.82349,401 shs$7.24 million03/06/2024$3.75$3.94+5.07%$4.00$3.50128,516 shs$6.14 million03/05/2024$3.77$3.75-0.53%$3.80$3.4870,087 shs$5.84 million03/04/2024$3.76$3.77+0.27%$3.80$3.4444,095 shs$5.87 million03/01/2024$3.62$3.76+3.87%$3.95$3.5973,304 shs$5.85 million02/29/2024$3.48$3.62+3.90%$3.78$3.4844,698 shs$5.64 million Related Companies: Senti Biosciences Stock Chart Tevogen Bio Stock Chart Inhibikase Therapeutics Stock Chart Coeptis Therapeutics Stock Chart Organovo Stock Chart Genetic Technologies Stock Chart BioCardia Stock Chart Chromocell Therapeutics Stock Chart Titan Pharmaceuticals Stock Chart Creative Medical Technology Stock Chart Receive TCON Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TRACON Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCON) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.